Cancer doctors in France face a tricky situation. They often mix up research goals with patient care. This mix-up is called therapeutic misconception (TM). It happens when people in studies think the main goal is to help them, not to find out new things for everyone. Oncologists deal with this a lo
By 2035, more than half of the planet's people might be overweight or obese. That's a big problem, but there's hope. Exercise, especially high-intensity interval training (HIIT), can help manage weight and improve health. But what if we could give workouts a little extra oomph? Enter therapeutic ul
Ovarian cancer treatment often involves surgery followed by chemotherapy. But when should the chemo start? This is a big question. A recent study looked into this. It wanted to see how the time between surgery and chemo affects survival rates. First, the basics. Ovarian cancer is serious. Surgery i
Zika virus is a big problem for pregnant women. It spreads through mosquito bites and can cause serious harm to unborn babies. The virus can cross the barrier between mother and baby, affecting the placenta. This is different from other viruses that spread through mosquitoes. The placenta is very i
Mario Cazzola has taken on a new role as an honorary editor for the journal Pulmonary Pharmacology & Therapeutics. This is a big deal because it means he gets to help shape the future of research in this field. But what does this really mean for the world of respiratory medicine? First, let's talk
Chronic myeloid leukemia, or CML, is a blood cancer that's defined by a specific genetic change. Doctors have been using drugs that target this change, called tyrosine kinase inhibitors, to treat CML. These drugs have been a game-changer, but some patients don't respond well and their condition wors
Doctors often use a machine to clean blood in very sick patients. This is called CRRT. Two common methods keep blood from clotting in the machine. One uses citrate. The other uses heparin. Both have pros and cons. But which one saves more money and works better? That's what experts wanted to find ou
Retinitis pigmentosa (RP) is a tricky condition. It's caused by faults in over 90 different genes. This makes it hard to treat because each case can be unique. Right now, gene therapies are limited and expensive. So, scientists are looking for a different approach. One that doesn't depend on the spe
Chordoma is a tough cancer to treat. It's rare, and doctors don't have many options. But there's a new drug called palbociclib that might help. Researchers tested palbociclib on people with advanced chordoma. They wanted to see if it could stop the cancer from growing. The results are promising. P
In a big move, Wisconsin's highest court just said the state can ban conversion therapy. This isn't just about one issue, though. It's also about who gets to make the rules in the state. The court said a group of lawmakers can't just block rules they don't like. This gives the governor more power to
